Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Century Therapeutics (IPSC) Interest & Investment Income (2022 - 2025)

Historic Interest & Investment Income for Century Therapeutics (IPSC) over the last 4 years, with Q3 2025 value amounting to $1.6 million.

  • Century Therapeutics' Interest & Investment Income fell 5143.72% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.9 million, marking a year-over-year decrease of 3459.0%. This contributed to the annual value of $13.0 million for FY2024, which is 260.31% up from last year.
  • Century Therapeutics' Interest & Investment Income amounted to $1.6 million in Q3 2025, which was down 5143.72% from $2.0 million recorded in Q2 2025.
  • In the past 5 years, Century Therapeutics' Interest & Investment Income registered a high of $3.6 million during Q2 2024, and its lowest value of $706000.0 during Q2 2022.
  • Over the past 4 years, Century Therapeutics' median Interest & Investment Income value was $2.9 million (recorded in 2024), while the average stood at $2.6 million.
  • As far as peak fluctuations go, Century Therapeutics' Interest & Investment Income surged by 33314.45% in 2023, and later tumbled by 5143.72% in 2025.
  • Over the past 4 years, Century Therapeutics' Interest & Investment Income (Quarter) stood at $1.4 million in 2022, then surged by 148.76% to $3.5 million in 2023, then dropped by 17.92% to $2.9 million in 2024, then plummeted by 44.29% to $1.6 million in 2025.
  • Its Interest & Investment Income stands at $1.6 million for Q3 2025, versus $2.0 million for Q2 2025 and $2.4 million for Q1 2025.